Biliary tract infection bacterial caused by susceptible Bacterial Infections

Drug	Drug Name	Drug Description
DB01327	Cefazolin	A broad-spectrum cephalosporin antibiotic mainly used for the treatment of skin bacterial infections and other moderate to severe bacterial infections in the lung, bone, joint, stomach, blood, heart valve, and urinary tract.

Drug	Drug Name	Target	Type
DB01327	Cefazolin	Serum paraoxonase/arylesterase 1	target
DB01327	Cefazolin	Serum albumin	carrier
DB01327	Cefazolin	Solute carrier family 22 member 6	transporter
DB01327	Cefazolin	Solute carrier family 22 member 8	transporter
DB01327	Cefazolin	Solute carrier family 22 member 11	transporter
DB01327	Cefazolin	Penicillin-binding protein 1A	target
DB01327	Cefazolin	Penicillin-binding protein 1B	target
DB01327	Cefazolin	Penicillin-binding protein 2	target
DB01327	Cefazolin	Penicillin-binding protein 1C	target
DB01327	Cefazolin	Peptidoglycan synthase FtsI	target
DB01327	Cefazolin	Multidrug resistance-associated protein 4	transporter
DB01327	Cefazolin	Thiopurine S-methyltransferase	enzyme
DB01327	Cefazolin	Interleukin-15	target
DB01327	Cefazolin	Interleukin-2	target

Drug	Drug Name	Phase	Status	Count